ALAMEDA, Calif.--(BUSINESS WIRE)--Avigen, Inc. (Nasdaq: AVGN), a biopharmaceutical company innovating therapeutics for neurological care, announced today that President and CEO Kenneth Chahine will present information on Avigen’s development programs and product pipeline at the Seventh Annual Needham & Company Biotechnology and Medical Technology Conference. Dr. Chahine will present on Thursday, June 12, from 11:00-11:30 a.m. ET at the New York Palace Hotel, New York City.
